Skip to main content
SpringerLink
Log in

Role of LASERS in stage 4A retinopathy of prematurity (ROP)

  • Original Article
  • Published:
Lasers in Medical Science Aims and scope Submit manuscript

Abstract

To study the anatomical success rate of light amplification by stimulated emission of radiation (LASERS) as first line of management in stage 4A retinopathy of prematurity (ROP). Observational, prospective case series of 14 eyes of 7 babies (males: 3, females: 4) with stage 4A ROP who underwent LASERS for stage 4A between January 2018 and July 2019. Gestation age (GA), birth weight (BW), and post-menstrual age (PMA) at which laser was done were noted in all cases. A number of clock hours of detachment at the time of presentation were noted in all babies. All babies were followed up up to 6 months after laser for any recurrence. Success was defined as complete regression of disease without the need of any other modality of treatment like anti-vascular endothelial growth factor (anti-VEGF) or pars plana vitrectomy. A total of 92.85% (13/14) showed complete regression of disease. One eye progressed to stage 4B ROP warranting lens-sparing vitrectomy (LSV). LASERS is an effective method of management without any need of anti-VEGF or surgical intervention even in babies with stage 4A ROP.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Data availability

Not applicable

References

  1. Sukgen etal EA (2017) Treatment for stage 4A retinopathy of prematurity: laser and/or ranibizumab. Graefes Arch Clin Exp Ophthalmol 255(2):263–269

    Article  Google Scholar 

  2. International Committee for the Classification of Retinopathy of Prematurity (2005) The international classification of retinopathy of prematurity revisited. Arch Ophthalmol 123:991–999

    Article  Google Scholar 

  3. Mueller B et al (2017) Treatment of type I ROP with intravitreal bevacizumab or laser photocoagulation according to retinal zone. Br J Ophthalmol 101:365–370

    CAS  PubMed  Google Scholar 

  4. Hwang et al (2015) Outcomes after Intravitreal bevacizumab versus laser photocoagulation for retinopathy of prematurity: a 5-year retrospective analysis. Ophthalmology 122(5):1008–1001

    Article  Google Scholar 

  5. Trese et al (2004) A fresh outlook on stage 4A ROP. Retinal Physician.

  6. Ferrone PJ, Harrison C, Trese MT (1997) Lens clarity after lens-sparing vitrectomy in a pediatric population. Ophthalmology. 104:273–278

    Article  CAS  Google Scholar 

  7. Wu W-C et al (2009) Vitrectomy for stage 4A retinopathy of prematurity (ROP). Invest Ophthalmol Vis Sci 50:3136

    Google Scholar 

  8. Wu W, Yeh P, Yang C et al (2011) Effects and Complications of bevacizmab use in patients with retinopathy of prematurity: a multicenter study in Taiwan. Ophthalmology 118:176–183

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Sarakshi Netralaya, 19, Rajiv Nagar, Wardha Road, Nagpur, Maharashtra, 440025, India

    Shilpi H. Narnaware & Prashant K. Bawankule

Authors
  1. Shilpi H. Narnaware
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prashant K. Bawankule
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shilpi H. Narnaware.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Consent to participate

Informed consent was obtained from all individual participant parents included in the study.

Consent for publication

Taken from parents.

Code availability

Not applicable

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Narnaware, S.H., Bawankule, P.K. Role of LASERS in stage 4A retinopathy of prematurity (ROP). Lasers Med Sci 36, 989–993 (2021). https://doi.org/10.1007/s10103-020-03130-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10103-020-03130-y

Keywords

Search

Navigation